for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Sartorius Stedim Biotech SA

STDM.PA

Latest Trade

130.60EUR

Change

-3.00(-2.25%)

Volume

112,138

Today's Range

130.10

 - 

136.20

52 Week Range

79.65

 - 

150.70

As of on the Euronext Paris ∙ Minimum 15 minute delay

Pricing

Previous Close
133.60
Open
134.10
Volume
112,138
3M AVG Volume
1.29
Today's High
136.20
Today's Low
130.10
52 Week High
150.70
52 Week Low
79.65
Shares Out (MIL)
92.18
Market Cap (MIL)
11,596.27
Forward P/E
47.54
Dividend (Yield %)
0.37

Next Event

Sartorius AG at Landesbank Baden Wuerttemberg Roadshow - Stuttgart

Latest Developments

More

Sartorius Stedim Biotech 9-Month EBITDA Up At EUR 312.3 Mln

Sartorius Stedim Biotech Signs Agreement To Acquire Parts Of Danaher Life Science

Sartorius Stedim Biotech H1 Underlying EBITDA At EUR 205.3 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Sartorius Stedim Biotech SA

Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The Company operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.

Industry

Medical Equipment & Supplies

Contact Info

Avenue de Jouques

Zone Industrielle les Paluds, C.S. 9105

Aubagne Cedex

+33.4.42845600

https://www.sartorius.com/en/company/about-sartorius-stedim-biotech-sa

Executive Leadership

Joachim Kreuzburg

Chairman of the Board and Chief Executive Officer, Chairman of the Executive Committee

Liliane de Lassus

Non-Executive Director

Lothar Kappich

Non-Executive Director

Bernard Lemaitre

Non-Executive Director

Susan Dexter

Non-Executive Independent Director

Key Stats

3.33 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2016

1.1K

2017

1.1K

2018

1.2K

2019(E)

1.4K
EPS (EUR)

2016

1.920

2017

1.960

2018

2.380

2019(E)

2.810
Price To Earnings (TTM)
48.57
Price To Sales (TTM)
8.68
Price To Book (MRQ)
10.55
Price To Cash Flow (TTM)
37.90
Total Debt To Equity (MRQ)
15.54
LT Debt To Equity (MRQ)
7.40
Return on Investment (TTM)
20.33
Return on Equity (TTM)
14.97

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up